Codes / ICD10CM / T49.4X1D

T49.4X1D Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), subsequent encounter

Summary

This condition refers to accidental poisoning from substances used in hair treatments, occurring during a subsequent encounter. These substances include keratolytic and keratoplastic agents, which may cause toxicity when ingested or improperly applied. The "subsequent encounter" designation indicates ongoing care following the initial incident.

Causes

The condition is caused by unintentional ingestion, inhalation, or improper application of hair treatment products containing harmful chemicals intended for external use. This may result from accidental exposure, misuse, or environmental factors leading to contact with toxic agents.

Risk Factors

  • Using hair treatment products in poorly ventilated areas.
  • Inadequate storage or labeling of products, especially around children.
  • Lack of awareness or disregard for product usage guidelines.
  • Previous history of accidental exposure to similar substances.

Symptoms

Symptoms may include nausea, vomiting, dizziness, skin irritation, difficulty breathing, and in severe cases, loss of consciousness. Systemic effects can vary based on the specific agent and exposure level.

Diagnosis

Diagnosis typically involves a physical examination and a review of the patient’s recent exposure history. Blood tests or other laboratory analyses may be used to identify specific toxins or abnormal chemical levels. Clinical assessment focuses on the nature and timing of exposure.

Treatment Options

Treatment typically involves supportive care such as monitoring vital signs, providing oxygen, and administering activated charcoal to limit absorption. Symptomatic management and addressing any complications are key components of care.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Follow-up care may include monitoring for delayed effects and ensuring complete recovery. Ongoing evaluation is necessary to address any residual symptoms or complications.

Complications

Potential complications include organ toxicity, respiratory distress, or allergic reactions. Severe cases may lead to long-term health issues if not properly managed.

Lifestyle & Prevention

  • Store hair treatment products in secure, labeled containers away from children.
  • Follow product instructions carefully and use in well-ventilated areas.
  • Avoid mixing or combining products without professional guidance.
  • Educate household members on safe handling and storage practices.

When to Seek Professional Help

Seek immediate medical attention if exposure occurs, especially with symptoms like difficulty breathing, severe nausea, or loss of consciousness. Prompt evaluation is critical to prevent worsening outcomes.

Tips for Medical Coders

Document the nature of the exposure (e.g., ingestion, inhalation) and the timing of the encounter (subsequent). Include details about the specific hair treatment product involved and any relevant clinical findings to support the diagnosis. Ensure the encounter is classified as "subsequent" based on the patient’s care timeline.

Book a walkthrough

T49.4X1D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.